Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Empty Capsule Market

ID: MRFR/Pharma/47490-HCR
200 Pages
Rahul Gotadki
Last Updated: May 05, 2026

UK Empty Capsule Market Research Report: Size, Share, Trend Analysis By Types (Gelatin Capsules, Vegetarian Capsules), By Functionality (Fast-release Capsules, Slow-release Capsules), By Physical Characteristics (Halal, Non-Halal), By Form (Hard Capsules, Soft Capsules), By Appearance (Transparent, Opaque) and By Applications (Pharmaceutical, Nutraceutical) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Empty Capsule Market Infographic
Purchase Options
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Medical Device, BY Type (USD Million) | |
      1. 4.1.1 Gelatin Capsules | |
      2. 4.1.2 Vegetarian Capsules |
    2. 4.2 Medical Device, BY Functionality (USD Million) | |
      1. 4.2.1 Fast-release Capsules | |
      2. 4.2.2 Slow-release Capsules |
    3. 4.3 Medical Device, BY Physical Characteristics (USD Million) | |
      1. 4.3.1 Halal | |
      2. 4.3.2 Non-Halal |
    4. 4.4 Medical Device, BY Form (USD Million) | |
      1. 4.4.1 Hard Capsules | |
      2. 4.4.2 Soft Capsules |
    5. 4.5 Medical Device, BY Appearance (USD Million) | |
      1. 4.5.1 Transparent | |
      2. 4.5.2 Opaque |
    6. 4.6 Medical Device, BY Application (USD Million) | |
      1. 4.6.1 Pharmaceutical | |
      2. 4.6.2 Nutraceutical 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Medical Device | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Capsugel (BE) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Qualicaps (JP) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 ACG Worldwide (IN) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Suheung Co Ltd (KR) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Lonza Group (CH) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Famar (FR) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Medisca (CA) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 Roxlor (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 Ginkgo BioWorks (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 UK MARKET ANALYSIS BY TYPE |
    6. 6.3 UK MARKET ANALYSIS BY FUNCTIONALITY |
    7. 6.4 UK MARKET ANALYSIS BY PHYSICAL CHARACTERISTICS |
    8. 6.5 UK MARKET ANALYSIS BY FORM |
    9. 6.6 UK MARKET ANALYSIS BY APPEARANCE |
    10. 6.7 UK MARKET ANALYSIS BY APPLICATION |
    11. 6.8 KEY BUYING CRITERIA OF MEDICAL DEVICE |
    12. 6.9 RESEARCH PROCESS OF MRFR |
    13. 6.10 DRO ANALYSIS OF MEDICAL DEVICE |
    14. 6.11 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE |
    15. 6.12 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE |
    16. 6.13 SUPPLY / VALUE CHAIN: MEDICAL DEVICE |
    17. 6.14 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE) |
    18. 6.15 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million) |
    19. 6.16 MEDICAL DEVICE, BY FUNCTIONALITY, 2024 (% SHARE) |
    20. 6.17 MEDICAL DEVICE, BY FUNCTIONALITY, 2024 TO 2035 (USD Million) |
    21. 6.18 MEDICAL DEVICE, BY PHYSICAL CHARACTERISTICS, 2024 (% SHARE) |
    22. 6.19 MEDICAL DEVICE, BY PHYSICAL CHARACTERISTICS, 2024 TO 2035 (USD Million) |
    23. 6.20 MEDICAL DEVICE, BY FORM, 2024 (% SHARE) |
    24. 6.21 MEDICAL DEVICE, BY FORM, 2024 TO 2035 (USD Million) |
    25. 6.22 MEDICAL DEVICE, BY APPEARANCE, 2024 (% SHARE) |
    26. 6.23 MEDICAL DEVICE, BY APPEARANCE, 2024 TO 2035 (USD Million) |
    27. 6.24 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE) |
    28. 6.25 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million) |
    29. 6.26 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    30. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    31. 7.2 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million) | |
      2. 7.2.2 BY FUNCTIONALITY, 2025-2035 (USD Million) | |
      3. 7.2.3 BY PHYSICAL CHARACTERISTICS, 2025-2035 (USD Million) | |
      4. 7.2.4 BY FORM, 2025-2035 (USD Million) | |
      5. 7.2.5 BY APPEARANCE, 2025-2035 (USD Million) | |
      6. 7.2.6 BY APPLICATION, 2025-2035 (USD Million) |
    32. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    33. 7.4 ACQUISITION/PARTNERSHIP | |

UK Medical Device Market Segmentation

Medical Device By Type (USD Million, 2025-2035)

  • Gelatin Capsules
  • Vegetarian Capsules

Medical Device By Functionality (USD Million, 2025-2035)

  • Fast-release Capsules
  • Slow-release Capsules

Medical Device By Physical Characteristics (USD Million, 2025-2035)

  • Halal
  • Non-Halal

Medical Device By Form (USD Million, 2025-2035)

  • Hard Capsules
  • Soft Capsules

Medical Device By Appearance (USD Million, 2025-2035)

  • Transparent
  • Opaque

Medical Device By Application (USD Million, 2025-2035)

  • Pharmaceutical
  • Nutraceutical

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions